Boston Scientific Corporation (BSX)

Market Cap	112.54B
Revenue (ttm)	14.71B
Net Income (ttm)	1.77B
Shares Out	1.47B
EPS (ttm)	1.19
PE Ratio	64.33
Forward PE	31.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,275,995
Open	76.39
Previous Close	76.41
Day's Range	75.91 - 76.73
52-Week Range	48.35 - 77.99
Beta	0.81
Analysts	Strong Buy
Price Target	77.41 (+1.12%)
Earnings Date	Jul 24, 2024

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 48,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX

Financial Performance

In 2023, BSX's revenue was $14.24 billion, an increase of 12.29% compared to the previous year's $12.68 billion. Earnings were $1.57 billion, an increase of 144.55%.

Analyst Forecast

According to 22 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is $77.41, which is an increase of 1.12% from the latest price.

Price Target

$77.41

(1.12% upside)

Analyst Consensus: Strong Buy